全文获取类型
收费全文 | 4329篇 |
免费 | 120篇 |
国内免费 | 517篇 |
出版年
2022年 | 9篇 |
2021年 | 10篇 |
2020年 | 5篇 |
2019年 | 5篇 |
2018年 | 12篇 |
2017年 | 20篇 |
2016年 | 29篇 |
2015年 | 64篇 |
2014年 | 51篇 |
2013年 | 56篇 |
2012年 | 73篇 |
2011年 | 457篇 |
2010年 | 339篇 |
2009年 | 101篇 |
2008年 | 78篇 |
2007年 | 66篇 |
2006年 | 37篇 |
2005年 | 287篇 |
2004年 | 539篇 |
2003年 | 276篇 |
2002年 | 172篇 |
2001年 | 206篇 |
2000年 | 83篇 |
1999年 | 82篇 |
1998年 | 69篇 |
1997年 | 118篇 |
1996年 | 75篇 |
1995年 | 92篇 |
1994年 | 33篇 |
1993年 | 332篇 |
1992年 | 262篇 |
1991年 | 136篇 |
1990年 | 104篇 |
1989年 | 101篇 |
1988年 | 101篇 |
1987年 | 91篇 |
1986年 | 66篇 |
1985年 | 96篇 |
1984年 | 31篇 |
1983年 | 10篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1977年 | 8篇 |
1962年 | 7篇 |
1957年 | 13篇 |
1956年 | 21篇 |
1955年 | 10篇 |
1943年 | 6篇 |
1924年 | 5篇 |
1923年 | 5篇 |
排序方式: 共有4966条查询结果,搜索用时 15 毫秒
351.
Jongen PJ Sindic C Sanders E Hawkins S Linssen W van Munster E Frequin S Borm G;Functional Composite Quality of Life in Avonex-treated Relapsing Multiple Sclerosis Patients Study Group 《PloS one》2011,6(10):e26568
Background
Due to methodological shortcomings the available post-registration data on the adverse events (AEs) occurring in interferon beta-1a (INFb-1a)-treated patients fail to adequately validate phase III data and only partially inform on safety in daily practice. We assessed AEs in relapsing remitting multiple sclerosis (RRMS) patients treated with intramuscular (IM) INFb-1a in daily practice using data quality assurance measures similar to those in phase III trials.Methods
A prospective, International Conference on Harmonization (ICH) - Good Clinical Practice (GCP)-based, clinical research organization (CRO)-supported study in 36 practices in the Netherlands, Belgium, the United Kingdom and Luxembourg. During 24 months after start of IM INFb-1a treatment 275 RRMS patients were assessed for AEs'' severity (mild, moderate, severe) and relationship to treatment (not, unlikely, likely, definite). Data were compared with those reported in the pivotal phase III trial.Findings
75.3% of the patients experienced one or more AEs that were likely or definitely related to INFb-1a. Of all AEs 40.5% were likely or definitely treatment-related; 68.5% of these were mild, and 3% severe. 6.6% of the patients discontinued treatment because of an AE. Compared to the pivotal phase III trial, we found statistically significantly lower incidences for most of the common AEs: headache, muscle ache, fatigue, fever, chills, nausea. One patient died following two cerebral vascular events in study month 22, both AEs were assessed as not related to INFb-1a.Conclusion
Three out of four RRMS patients treated with IM INFb-1a in daily practice experience treatment-related AEs, most of these being mild. Our data externally validate the favorable phase III safety profile of IM INFb-1a and suggest that the real-life incidence of treatment-related AEs is less than reported in the pivotal phase III trial. Larger studies are needed to detect rare, potentially hazardous AEs of IM INFb-1a. 相似文献352.
353.
Valentin-Domelier AS Girard M Bertrand X Violette J François P Donnio PY Talon D Quentin R Schrenzel J van der Mee-Marquet N;Bloodstream Infection Study Group of the Réseau des Hygiénistes du Centre 《PloS one》2011,6(12):e28369
In the course of an annual 3-month bloodstream infections (BSI) survey conducted during a four-year period in 31 healthcare institutions located in three noncontiguous French regions, we report 18 ST398 Staphylococcus aureus BSI. ST398 BSI incidence showed a seven-fold increase during the study period (0.002 per 1,000 patient days in 2007 vs. 0.014 in 2010). ST398 BSI isolates differed from the pig-borne multiresistant clone: 17/18 BSI isolates were methicillin susceptible and none was of t011, t034 or t108 pig-borne spa-types. ST398 BSI isolates had homogenous resistance patterns (15/18 with only Ery(r)) and prophagic content (all harboured the hlb-converting Sau3int phage). The clustering of BSI and pig-borne isolates by spa-typing and MLVA, the occurrence of Sau3int phage in BSI isolates and the lack of this phage in pig-borne isolates suggest that the emergence of BSI isolates could have arisen from horizontal transfer, at least of the Sau3int phage, in genetically diverse MSSA ST398 isolates. The acquisition of the phage likely plays a role in the increasing ability of the lysogenic ST398 isolates to colonize human. The mode of acquisition of the non pig-borne ST398 isolates by our 18 patients remains unclear. ST398 BSI were diagnosed in patients lacking livestock exposure and were significantly associated with digestive portals of entry (3/18 [16.7%] for ST398 vs. 19/767 [2.5%] for non ST398 BSI; p?=?.012). This raises the question of possible foodborne human infections. We suggest the need for active surveillance to study and control the spread of this human-adapted subclone increasingly isolated in the hospital setting. 相似文献
354.
Ohmori K Umeda M Tanaka N Takagi H Yoshimura I Sasaki K Asasda S Sakai A Araki H Asakura M Baba H Fushiwaki Y Hamada S Kitou N Nakamura T Nakamura Y Oishi H Sasaki S Shimada S Tsuchiya T Uno Y Washizuka M Yajima S Yamamoto Y Yamamura E Yatsushiro T;Non-Genotoxic Carcinogen Study Group in the Environmental Mutagen Society of Japan 《Alternatives to laboratory animals : ATLA》2005,33(6):619-639
The Bhas promotion assay is a cell culture transformation assay designed as a sensitive and economical method for detecting the tumour-promoting activities of chemicals. In order to validate the transferability and applicability of this assay, an inter-laboratory collaborative study was conducted with the participation of 14 laboratories. After confirmation that these laboratories could obtain positive results with two tumour promoters, 12-O-tetradecanoylphorbol-13-acetate (TPA) and lithocholic acid (LCA), 12 coded chemicals were assayed. Each chemical was tested in four laboratories. For eight chemicals, all four laboratories obtained consistent results, and for two of the other four chemicals, only one of the four laboratories showed inconsistent results. Thus, the rate of consistency was high. During the study, several issues were raised, each of which were analysed step-by-step, leading to revision of the protocol of the original assay. Among these issues were the importance of careful maintenance of mother cultures and the adoption of test concentrations for toxic chemicals. In addition, it is suggested that three different types of chemicals show positive promoting activity in the assay. Those designated as T-type induced extreme growth enhancement, and included TPA, mezerein, PDD and insulin. LCA and okadaic acid belonged to the L-type category, in which transformed foci were induced at concentrations showing growth-inhibition. In contrast, M-type chemicals, progesterone, catechol and sodium saccharin, induced foci at concentrations with little or slight growth inhibition. The fact that different types of chemicals similarly induce transformed foci in the Bhas promotion assay may provide clues for elucidating mechanisms of tumour promotion. 相似文献
355.
Parsons PE Matthay MA Ware LB Eisner MD;National Heart Lung Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network 《American journal of physiology. Lung cellular and molecular physiology》2005,288(3):L426-L431
Ventilator-induced lung injury (VILI) is an inflammatory process that can be attenuated by lung protective ventilation strategies. Our objectives to further investigate the pathogenesis of ALI and VILI and the mechanism of lung protection in these syndromes were: 1) to determine if plasma measurements of soluble TNF receptor I (sTNFRI) and II (sTNFRII) would predict the development of ALI and mortality in a small single center trial; 2) to test the predictive value of these markers and of TNF-alpha in a larger, broader group of patients with ALI; 3) to test the hypothesis that low tidal volume ventilation (LTVV) would be associated with a decrease in plasma levels of TNF-alpha, sTNFRI, and sTNFRII. In the single center study, sTNFRI and II levels were higher in patients at risk for and with ALI, but they did not predict the development of the syndrome. In the multicenter trial sTNFRI and II were strongly associated with mortality (OR 5.76/1 log10 increment in receptor level; 95% CI 2.63-12.6 and OR 2.58; 95% CI 1.05-6.31, respectively) and morbidity measured as fewer nonpulmonary organ failure-free and ventilator-free days. The LTVV strategy was associated with an attenuation of plasma sTNFRI levels. In vitro, stimulated A549 cells release sTNFRI but not sTNRFII. In conclusion, plasma levels of sTNFRI and II can serve as biomarkers for morbidity and mortality in patients with ALI. Furthermore, LTVV is associated with a specific decrease in sTNFRI levels. This suggests that one beneficial effect of LTVV may be to attenuate alveolar epithelial injury. 相似文献
356.
357.
Meriño-Ibarra E Castillo S Mozas P Cenarro A Martorell E Díaz JL Suárez-Tembra M Alonso R Civeira F Mata P Pocoví M;Spanish Group of Familial Hypercholesterolemia 《Human biology; an international record of research》2005,77(5):663-673
Monogenic hypercholesterolemia is a group of lipid disorders, most of which have autosomal dominant transmission. Familial defective apoB (FDB) resulting from mutations in the APOB gene is a well-recognized cause of autosomal dominant monogenic hypercholesterolemia (ADMH). However, the frequency of FDB among patients with ADMH is not well established. The aim of our research was to screen for mutations responsible for FDB in subjects with a clinical diagnosis of familial hypercholesterolemia. We studied 408 patients from the Spanish Register of Familial Hypercholesterolemia, proportionally distributed among all Spanish regions. Abnormal SSCP patterns of the APOB gene were checked by DNA sequencing and restriction analysis. Three out of the 408 patients were carriers of the R3500Q mutation, and 2 subjects were carriers of the silent T3552T mutation; in both of these patients functional mutations in the LDL receptor gene were found. We conclude that FDB is not a common cause of ADMH in Spain; the R3500Q mutation is the only mutation in APOB causing FDB, and the LDL receptor binding domain of APOB is highly conserved in the studied sample. 相似文献
358.
Hashimoto T Matsumoto MM Li JF Lawton MT Young WL;University of California San Francisco BAVM Study Group 《BMC neurology》2005,5(1):1
Background
The primary aim of this study is to demonstrate the feasibility of utilizing doxycycline to suppress matrix metalloproteinase-9 (MMP-9) in brain arteriovenous malformations (AVMs). 相似文献359.
360.